Abdul Haseeb Hasan

13PUBLICATIONS
23CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsAutoimmunityTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 28, 2026
Sublingual Cyclobenzaprine Approval: Expanding Options for Fibromyalgia Management.

|Jul 11, 2026
FDA approves IcotydeTM (Icotrokinra): a novel IL-23 receptor antagonist for plaque psoriasis.

|Jul 11, 2026
From pancreatic ductal adenocarcinoma to non-small cell lung cancer: daraxonrasib in the RASolute 302 trial - a pan-RAS(ON) breakthrough or the next evolution in targeting diverse oncogenic RAS variants?

|Jul 11, 2026
Antiphospholipid syndrome-associated myocarditis: role of 18F-FDG PET/CT in differentiation from immune-mediated or viral etiologies.

|Jul 11, 2026
Daraxonrasib in metastatic pancreatic cancer (RASolute 302): survival breakthrough or real-world access barrier?

|Jul 11, 2026
Bridging pathogenesis and therapy in focal segmental glomerulosclerosis: the rise of dual receptor blockade with sparsentan.

Pageof 3

Frequent Collaborators

4 joint publications

Muhammad Ali Abid

4 joint publications

Muhammad Qaseem

3 joint publications

Muhammad Daniyal Afzal

3 joint publications

Muhammad Hafi Abid